Site-specific steric control of SARS-CoV-2 spike glycosylation
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
Site-specific steric control of SARS-CoV-2 spike glycosylation
JD Allen, H Chawla, L Zuzic, AT Shivgan… - …, 2021 - eprints.soton.ac.uk
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
Site-specific steric control of SARS-CoV-2 spike glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan… - 2021 - pesquisa.bvsalud.org
Site-specific steric control of SARS-CoV-2 spike glycosylation | PREPRINT-BIORXIV loading 1
2 3 +A A -A 3.Site-specific steric control of SARS-CoV-2 spike glycosylation This article is a …
2 3 +A A -A 3.Site-specific steric control of SARS-CoV-2 spike glycosylation This article is a …
[HTML][HTML] Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic… - Biochemistry, 2021 - ncbi.nlm.nih.gov
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
[PDF][PDF] Site-Specific Steric Control of SARS-CoV‑2 Spike Glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan… - researchgate.net
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
Site-specific steric control of SARS-CoV-2 spike glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan… - bioRxiv, 2021 - biorxiv.org
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
[PDF][PDF] Site-Specific Steric Control of SARS-CoV‑2 Spike Glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic… - …, 2021 - scholar.archive.org
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
[HTML][HTML] Site-specific steric control of SARS-CoV-2 spike glycosylation
JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan… - 2021 - europepmc.org
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
JD Allen, H Chawla, F Samsudin… - …, 2021 - researchinformation.amsterdamumc …
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
[PDF][PDF] Site-Specific Steric Control of SARS-CoV‑2 Spike Glycosylation
Biochemistry, 2021 - academia.edu
A central tenet in the design of vaccines is the display of native-like antigens in the elicitation
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
of protective immunity. The abundance of N-linked glycans across the SARS-CoV-2 spike …
